RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 118 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $2,421,000 | -27.0% | 913,621 | 0.0% | 0.73% | -30.9% |
Q3 2021 | $3,316,000 | -7.9% | 913,621 | +10.1% | 1.06% | +18.1% |
Q2 2021 | $3,601,000 | -12.9% | 829,721 | -48.4% | 0.90% | -19.9% |
Q1 2019 | $4,136,000 | -17.5% | 1,609,265 | -26.2% | 1.12% | -38.9% |
Q4 2018 | $5,015,000 | -15.3% | 2,180,546 | +18.3% | 1.83% | -10.0% |
Q3 2018 | $5,918,000 | +49.5% | 1,843,501 | +31.8% | 2.03% | -7.2% |
Q2 2018 | $3,958,000 | +15.3% | 1,398,618 | +58.0% | 2.19% | +13.0% |
Q4 2017 | $3,434,000 | -13.5% | 885,055 | -43.4% | 1.94% | -6.0% |
Q3 2017 | $3,971,000 | +8.1% | 1,563,307 | +16.2% | 2.06% | +18.0% |
Q2 2017 | $3,674,000 | -41.2% | 1,345,723 | -28.7% | 1.75% | -50.1% |
Q1 2017 | $6,250,000 | +107.8% | 1,888,181 | +49.5% | 3.50% | +99.3% |
Q4 2016 | $3,007,000 | -19.7% | 1,263,390 | +23.8% | 1.75% | -32.1% |
Q3 2016 | $3,746,000 | +26.0% | 1,020,719 | -23.5% | 2.58% | +70.0% |
Q2 2016 | $2,974,000 | -11.6% | 1,333,696 | -17.5% | 1.52% | +23.4% |
Q1 2016 | $3,363,000 | – | 1,616,896 | – | 1.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |